Immune response may be harnessed to control HIV, primary trial results suggest

Published Date: 12 Mar 2025

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by immune-based therapies.

Read Full News

Latest News

WHO Says Congo Ebola Outbreak Can Still Be Brought Under Control Within Three Months

A World Health Organization official said on Tuesday it was still possible to bring under control an ⁠Ebola outbreak that is outpacing containment efforts and has become the...

Do TZP-Resistant Bloodstream Infections Raise Death Risk?

Piperacillin-tazobactam resistance does not increase mortality risk in patients with bloodstream infections after accounting for baseline risk factors, a recent study shows.

Data Trends: Pneumococcal Disease Prevention

Pneumococcal disease prevention is evolving fast with updated vaccine recommendations for adults 50+ and exciting next-generation vaccines on the horizon.

Netherlands Reports First West Nile Virus Infection in 6 Years

A West Nile virus infection has ⁠been detected in the Netherlands for the first ⁠time since 2020, Dutch public health institution ⁠RIVM said on ‌Monday.

Ebola Outbreak in Democratic Republic Of Congo Becomes Deadliest in Country's History

The Ebola outbreak in Democratic Republic of Congo has killed 2,325 people, government data showed on Sunday, surpassing the toll from the 2018-2020 outbreak to become the...

Doxycycline Cuts Recurrent Rectal Chlamydia Risk

A shift in prescribing practices at a Seattle sexual health clinic corresponded with a notable decline in recurrent rectal chlamydia cases among men who have sex with men.

Todays Updates

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

Todays Updates

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

Latest News

A World Health Organization official said on Tuesday it was still possible to bring under control an ⁠Ebola outbreak that is outpacing containment efforts and has become the...

Piperacillin-tazobactam resistance does not increase mortality risk in patients with bloodstream infections after accounting for baseline risk factors, a recent study shows.

Pneumococcal disease prevention is evolving fast with updated vaccine recommendations for adults 50+ and exciting next-generation vaccines on the horizon.

A West Nile virus infection has ⁠been detected in the Netherlands for the first ⁠time since 2020, Dutch public health institution ⁠RIVM said on ‌Monday.

The Ebola outbreak in Democratic Republic of Congo has killed 2,325 people, government data showed on Sunday, surpassing the toll from the 2018-2020 outbreak to become the...

A shift in prescribing practices at a Seattle sexual health clinic corresponded with a notable decline in recurrent rectal chlamydia cases among men who have sex with men.

News All Time

Meningococcal B Vaccine May Cut Gonorrhea Risk in Teens

A multicomponent meningococcal B vaccine showed modest protection against gonorrhea in a high-burden population, a study shows.

Encephalitis Linked to Long-Term Dementia Risk

Survivors of encephalitis face elevated dementia risk years later, with the magnitude varying by age and etiology, a study shows.

Australia to Vaccinate Vulnerable Native Birds Against Bird Flu

Australia will soon begin vaccinating its vulnerable native birds against the deadly H5N1 bird ⁠flu as the virus spreads more widely after first being detected in the...

New Transmission From Animals Likely Caused Congo-Uganda Ebola Outbreak, Study Says

The ongoing Ebola outbreak in Democratic Republic of Congo concerns a previously unseen ⁠variant of the rare Bundibugyo species of the virus, indicating it stemmed from a...

HIV and Hepatitis C Screening at Appalachian Music Festival

A similar model of bringing testing into less engaged communities could potentially be implemented elsewhere with adequate funding, resources, and buy-in.

HIV Care Disengagement Common in Missouri

A pattern of cycling in and out of care challenges the linear depiction of the HIV care continuum, with implications for retention strategies in priority jurisdictions.

Roche Launches Two New Cyclospora Tests as US Outbreak Widens

Roche said on Thursday it launched two new tests to detect cyclospora, as ⁠U.S. cyclosporiasis cases climbed to record levels this year making the foodborne-illness outbreak...

Michigan Eases Lettuce Advice as State Health Department Says Cyclosporiasis Reports Decline

Michigan health officials on Thursday advised residents to resume eating lettuce and salad greens, citing a slowdown in new cyclosporiasis infections, after reporting...

US Will Nearly Double Financial Commitment to Ebola Response

The U.S. State Department on Wednesday nearly doubled its financial commitment to the Ebola response in eastern Democratic Republic of Congo, announcing ⁠plans to provide an...

US FDA Approves First MRNA Flu Shot From Moderna

The U.S. Food and Drug Administration has approved Moderna's flu vaccine for people aged 50 and older, the company said on Wednesday, marking the first approval ⁠of a...

Senate Confirms Schwartz to Lead CDC

The long-time public servant is leaving a position with UnitedHealth to return to the health agency.

Congo Intercepts Boat That Carried Suspected Ebola Case

Congolese health authorities have intercepted a boat carrying 200 people to the capital ⁠Kinshasa after a passenger who had disembarked earlier died on July 25. after...

Baseline Steroids Fail to Benefit Bronchiectasis Patients

Observational data show an association between baseline inhaled corticosteroid use and poor outcomes after a year.

CDC Expands Largest Known Cyclosporiasis Outbreak to 15 States, Washington Post Reports

The U.S. CDC is adding six more states to the cyclosporiasis outbreak linked to iceberg lettuce, widening ⁠the number of affected states to 15, the Washington Post reported...

Moderna Begins First Human Trial of Bundibugyo Ebola Vaccine

Moderna said it has begun its first human trial of an experimental vaccine to ⁠protect against Bundibugyo ebolavirus, a strain that has killed more than 1650 people so far.